Stay updated on Relatlimab Safety in B-Cell Malignancies Clinical Trial

Sign up to get notified when there's something new on the Relatlimab Safety in B-Cell Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab Safety in B-Cell Malignancies Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.6.6 is now listed on the page, replacing the previous Revision: v3.6.5.
    Difference
    0.0%
    Check dated 2026-09-01T19:58:24.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Expanded metadata and resources are added to the study record, including more MeSH terms, publications references, and sponsor/links in the More Information area.
    Difference
    68%
    Check dated 2026-08-11T18:39:32.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    A large set of searchable keywords and related terms were removed from the page, reducing indexing and keyword-based navigation without altering the core study details.
    Difference
    19%
    Check dated 2026-08-04T16:08:33.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.6.3 to v3.6.4, signaling a maintenance update to the page. There are no changes to the study details or visible content.
    Difference
    0.1%
    Check dated 2026-07-28T13:23:16.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.6.0 to v3.6.3, signaling a refreshed version of the study record content.
    Difference
    0.0%
    Check dated 2026-06-30T00:39:22.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Recruitment status is updated to 'No longer looking for participants', indicating enrollment for the study has ended. Additional edits add new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and adjust the Intervention/Treatment labeling and a site revision note, reflecting formatting and navigational updates.
    Difference
    0.4%
    Check dated 2026-06-15T20:00:29.000Z thumbnail image

Stay in the know with updates to Relatlimab Safety in B-Cell Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab Safety in B-Cell Malignancies Clinical Trial page.